These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4896220)

  • 21. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Should we still fear the plague today?].
    Guinet F; Carniel E
    Med Sci (Paris); 2008 Oct; 24(10):865-8. PubMed ID: 18950584
    [No Abstract]   [Full Text] [Related]  

  • 23. Deadly plague versus mild-mannered TLR4.
    Dziarski R
    Nat Immunol; 2006 Oct; 7(10):1017-9. PubMed ID: 16985495
    [No Abstract]   [Full Text] [Related]  

  • 24. Trapping and serum testing of rodents caught prior to the outbreak of plague in Rhodesia.
    Swanepoel R; Blackburn NK; Condy JB
    Cent Afr J Med; 1976 Jul; 22(7):131-3. PubMed ID: 963739
    [No Abstract]   [Full Text] [Related]  

  • 25. [Plague in the world during the years 1960-1965].
    Jervis O
    Rev Ecuat Hig Med Trop; 1967; 24(1):77-84. PubMed ID: 5601132
    [No Abstract]   [Full Text] [Related]  

  • 26. A plague upon the phagocytes.
    DeLeo FR; Hinnebusch BJ
    Nat Med; 2005 Sep; 11(9):927-8. PubMed ID: 16145573
    [No Abstract]   [Full Text] [Related]  

  • 27. Large-scale purification of the F1 antigen of Yersinia pestis.
    Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R
    Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865
    [No Abstract]   [Full Text] [Related]  

  • 28. A filtered non-toxic plague vaccine which protects guinea-pigs and mice.
    Smith H; Packman LP
    Br J Exp Pathol; 1966 Feb; 47(1):25-34. PubMed ID: 5908699
    [No Abstract]   [Full Text] [Related]  

  • 29. Susceptibility of rodents to oral plague infection: a mechanism for the persistence of plague in inter-epidemic periods.
    Rust JH; Harrison DN; Marshall JD; Cavanaugh DC
    J Wildl Dis; 1972 Apr; 8(2):127-33. PubMed ID: 5020998
    [No Abstract]   [Full Text] [Related]  

  • 30. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigations on plague foci in Mahasu District of Himachal Pradesh.
    Krishnaswami AK; Rao CK; Chandrahas RK; Samuel D; Ravindran PC
    Indian J Med Res; 1972 Aug; 60(8):1126-31. PubMed ID: 4661463
    [No Abstract]   [Full Text] [Related]  

  • 32. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
    Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug resistance in plague.
    Dennis DT; Hughes JM
    N Engl J Med; 1997 Sep; 337(10):702-4. PubMed ID: 9278470
    [No Abstract]   [Full Text] [Related]  

  • 34. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.
    Palin A; Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
    Vaccine; 2007 Jan; 25(4):741-50. PubMed ID: 16959385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-plague vaccination: past and future perspectives].
    Merlin M
    Bull Soc Pathol Exot; 1999 Dec; 92(5 Pt 2):427-31. PubMed ID: 11000956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Historical review of the plague in South America: a little-known disease in Colombia].
    Faccini-Martínez ÁA; Sotomayor HA
    Biomedica; 2013; 33(1):8-27. PubMed ID: 23715302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
    Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigations on the epidemiology and control of plague in South Vietnam. Part I (author's transl)].
    Velimirovic B
    Zentralbl Bakteriol Orig A; 1974 Sep; 228(4):482-508. PubMed ID: 4155201
    [No Abstract]   [Full Text] [Related]  

  • 39. Plague: Bridging gaps towards better disease control.
    D'Ortenzio E; Lemaître N; Brouat C; Loubet P; Sebbane F; Rajerison M; Baril L; Yazdanpanah Y
    Med Mal Infect; 2018 Aug; 48(5):307-317. PubMed ID: 29773334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plague.
    Henderson RJ
    Trop Dis Bull; 1971 Jul; 68(7):777-83. PubMed ID: 5559418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.